Reviral is an England-based biopharmaceutical company that develops and commercializes antiviral therapeutics for the treatment of the respiratory syncytial virus... Read more
Reviral is an England-based biopharmaceutical company that develops and commercializes antiviral therapeutics for the treatment of the respiratory syncytial virus... Read more
News
Jun 13, 2022
The Financial Express
ReViral: Pfizer acquires clinical-stage biopharma firm ReViral for up to $525m
Jun 10, 2022
Competition Policy International
ReViral: Pfizer Completes Acquisition Of ReViral
Jun 09, 2022
Citybizlist
ReViral: Pfizer Acquires ReViral
Apr 26, 2022
Business Live UK
ReViral: Biotech firm ReViral acquired by Pfizer in 412m deal
Apr 12, 2022
Global Legal Chronicle
ReViral: Pfizer's $525 Million Acquisition of ReViral
Apr 11, 2022
Explode Africa
ReViral: Pfizer to Purchase ReViral, Up To $525M
Apr 08, 2022
Drug Discovery and Development
ReViral: Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates
Apr 08, 2022
FirstWord Pharma
ReViral: LianBio's Partner ReViral Enters into Acquisition Agreement with Pfizer
Apr 08, 2022
PMLiVE
ReViral: Pfizer and viral infection specialist ReViral agree on $525m deal
Apr 07, 2022
PharmaLive
ReViral: Pfizer boosts respiratory drug portfolio with ReViral purchase
ReViral Competitors
1
2
3
4
5
6
7
8
9
10